Changes in Lymphocyte Subpopulations after Remdesivir Therapy for COVID-19: A Brief Report

Changes in Lymphocyte Subpopulations after Remdesivir Therapy for COVID-19: A Brief Report

Remdesivir (RDV) has demonstrated clinical benefit in hospitalized COronaVIrus Disease (COVID)-19 patients. The objective of this brief report was to assess a possible correlation between RDV therapy and the variation in lymphocyte subpopulations. We retrospectively studied 43 hospitalized COVID-19...

Full description

Bibliographic Details
Main Authors: Rossella Cianci, Maria Grazia Massaro, Elisabetta De Santis, Beatrice Totti, Antonio Gasbarrini, Giovanni Gambassi, Vincenzo Giambra
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:International Journal of Molecular Sciences
Subjects:
COVID-19 disease
lymphocyte subpopulations
remdesivir
immune modulation
Online Access:https://www.mdpi.com/1422-0067/24/19/14973

Internet

https://www.mdpi.com/1422-0067/24/19/14973

Similar Items